| Intervention methods | Results | Animal/human study |
---|---|---|---|
LT | Reducing the high incidence of infection [81] | Human study | |
Gram-positive microorganisms infection predominated over Gram-negative rods and anaerobes [82] | Human study | ||
Human study | |||
Antibiotics [57] | Partly ameliorating enhanced ischemia/reperfusion injury | Animal study | |
LAB and fibers [87] | Reducing bacterial infection rates | Human study | |
Only fibers [87] | Reducing incidence of severe infections | Human study | |
Promoting partial restoration of intestinal microflora and improving intestinal barrier function [88] | Animal study | ||
Reducing the liver injury by acute rejection [89] | Animal study | ||
SBT | Probiotics [90] | Ameliorating small bowel histological injuries and reducing BT | Animal study |
HSCT | TGID [86] | Preventing acute GVHD | Human study |
Polymyxin B [70] | Ameliorating GVHD | Animal study | |
Probiotics [91] | Reduceing acute GVHD and improving survival | Animal study |